Read + Share
Amedeo Smart
Independent Medical Education
Sharma M, Nayar R, Graham Y, Parretti HM, et al. Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery. Obes Surg 2022;32:2469-2470.PMID: 35482224
Email
LinkedIn
Facebook
Twitter
Privacy Policy